168 related articles for article (PubMed ID: 36387093)
1. Impact of perioperative blood transfusion on long-term survival in patients with different stages of perihilar cholangiocarcinoma treated with curative resection:
Liu ZP; Cheng ZJ; Dai HS; Zhong SY; Zhao DC; Gong Y; Zuo JH; Che XY; Chen WY; Wang ZR; Yu T; Cheng JJ; Liu XC; Bai J; Jiang Y; Zhang YQ; Lau WY; Deng SQ; Chen ZY
Front Oncol; 2022; 12():1059581. PubMed ID: 36387093
[TBL] [Abstract][Full Text] [Related]
2. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
[TBL] [Abstract][Full Text] [Related]
3. Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
Zhou PY; Tang Z; Liu WR; Tian MX; Jin L; Jiang XF; Wang H; Tao CY; Ding ZB; Peng YF; Qiu SJ; Dai Z; Zhou J; Fan J; Shi YH
BMC Cancer; 2017 Nov; 17(1):762. PubMed ID: 29137600
[TBL] [Abstract][Full Text] [Related]
4. Impact of perioperative allogeneic blood transfusion on the long-term prognosis of patients with different stage tumors after radical resection for hepatocellular carcinoma.
Peng T; Wang L; Cui H; Li X; Liu M; Yu J; Wu J; Zhao G; Liu Z
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):620-627. PubMed ID: 32988700
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection:
Ge MY; Liu ZP; Pan Y; Wang JY; Wang X; Dai HS; Gao SY; Zhong SY; Che XY; Zuo JH; Liu YH; Liu XC; Fan HN; Chen WY; Wang ZR; Yin XY; Bai J; Zhang YQ; Jiang Y; Gong Y; Chen ZY
Front Oncol; 2022; 12():1104810. PubMed ID: 36686802
[TBL] [Abstract][Full Text] [Related]
6. Effect of Perioperative Blood Transfusion on the Postoperative Prognosis of Ruptured Hepatocellular Carcinoma Patients With Different BCLC Stages: A Propensity Score Matching Analysis.
Xia F; Zhang Q; Huang Z; Ndhlovu E; Zhang M; Chen X; Zhang B; Zhu P
Front Surg; 2022; 9():863790. PubMed ID: 35392056
[TBL] [Abstract][Full Text] [Related]
7. Development of a model based on the age-adjusted Charlson comorbidity index to predict survival for resected perihilar cholangiocarcinoma.
Pan Y; Liu ZP; Dai HS; Chen WY; Luo Y; Wang YZ; Gao SY; Wang ZR; Dong JL; Liu YH; Yin XY; Liu XC; Fan HN; Bai J; Jiang Y; Cheng JJ; Zhang YQ; Chen ZY
World J Gastrointest Oncol; 2023 Jun; 15(6):1036-1050. PubMed ID: 37389112
[TBL] [Abstract][Full Text] [Related]
8. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Prognostic Model to Predict Recurrence-Free Survival After Curative Resection for Perihilar Cholangiocarcinoma: A Multicenter Study.
Liu ZP; Chen WY; Wang ZR; Liu XC; Fan HN; Xu L; Pan Y; Zhong SY; Xie D; Bai J; Jiang Y; Zhang YQ; Dai HS; Chen ZY
Front Oncol; 2022; 12():849053. PubMed ID: 35530316
[TBL] [Abstract][Full Text] [Related]
10. Survival Impact of Perioperative Red Blood Cell Transfusion During Pancreatectomy in Patients With Pancreatic Ductal Adenocarcinoma: A Propensity Score Matching Analysis.
Kitano Y; Yamashita YI; Matsumoto T; Kinoshita S; Itoyama R; Kaida T; Hayashi H; Imai K; Chikamoto A; Baba H
Pancreas; 2022 Feb; 51(2):200-204. PubMed ID: 35404898
[TBL] [Abstract][Full Text] [Related]
11. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.
Zhao J; Zhang W; Zhang J; Zhang Y; Ma WJ; Liu SY; Li FY; Song B
BMC Cancer; 2020 Sep; 20(1):849. PubMed ID: 32883228
[TBL] [Abstract][Full Text] [Related]
12. Impact of Body Mass Index on Tumor Recurrence in Patients Undergoing Liver Resection for Perihilar Cholangiocarcinoma (pCCA).
Hau HM; Devantier M; Jahn N; Sucher E; Rademacher S; Seehofer D; Sucher R
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638257
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Impact of Perioperative CA19-9 Levels in Patients with Resected Perihilar Cholangiocarcinoma.
Lee JW; Lee JH; Park Y; Kwon J; Lee W; Song KB; Hwang DW; Kim SC
J Clin Med; 2021 Mar; 10(7):. PubMed ID: 33805079
[TBL] [Abstract][Full Text] [Related]
14. Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma.
Geers J; Jaekers J; Topal H; Aerts R; Vandoren C; Vanden Boer G; Topal B
World J Surg Oncol; 2020 Nov; 18(1):286. PubMed ID: 33143698
[TBL] [Abstract][Full Text] [Related]
15. Perioperative blood transfusion has no effect on overall survival after esophageal resection for esophageal squamous cell carcinoma: A retrospective cohort study.
Liu J; Chen S; Chen Y; Wang N; Ye X
Int J Surg; 2018 Jul; 55():24-30. PubMed ID: 29578096
[TBL] [Abstract][Full Text] [Related]
16. [Surgical treatment for perihilar cholangiocarcinoma:a single-center experience].
Deng WY; Shi XD; Ye YF; Tang QB; Lin HM; Yu XH; Liu C
Zhonghua Wai Ke Za Zhi; 2023 Mar; 61(5):381-388. PubMed ID: 36987672
[No Abstract] [Full Text] [Related]
17. Evaluation of the short-term outcomes of robotic-assisted radical resection for perihilar cholangiocarcinoma: a propensity-scored matching analysis.
Huang XT; Xie JZ; Cai JP; Chen W; Chen LH; Liang LJ; Yin XY
Gastroenterol Rep (Oxf); 2023; 11():goad018. PubMed ID: 37051578
[TBL] [Abstract][Full Text] [Related]
18. Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand.
Aphivatanasiri C; Sa-Ngiamwibool P; Sangkhamanon S; Intarawichian P; Kunprom W; Thanee M; Prajumwongs P; Khuntikeo N; Titapun A; Jareanrat A; Thanasukarn V; Srisuk T; Luvira V; Eurboonyanun K; Promsorn J; Loilome W; Wee A; Koonmee S
Front Med (Lausanne); 2022; 9():893252. PubMed ID: 36250068
[TBL] [Abstract][Full Text] [Related]
19. Does perioperative allogeneic blood transfusion worsen the prognosis of patients with hepatocellular carcinoma? A meta-analysis of propensity score-matched studies.
Hu L; Li Z; Qiao Y; Wang A
Front Oncol; 2023; 13():1230882. PubMed ID: 37854678
[TBL] [Abstract][Full Text] [Related]
20. Impact of perioperative blood transfusion on oncological outcomes in ampullary carcinoma patients underwent pancreaticoduodenectomy.
Fei H; Zhang XJ; Sun CY; Li Z; Li ZF; Guo CG; Zhao DB
World J Gastrointest Surg; 2023 Jul; 15(7):1363-1374. PubMed ID: 37555106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
